Truist Securities Downgrades PacWest Banc to Hold, Announces $26 Price Target

Truist Securities analyst Brandon King downgrades PacWest Banc (NASDAQ:PACW) from Buy to Hold and announces $26 price target.

Truist Securities analyst Brandon King downgrades PacWest Banc (NASDAQ:PACW) from Buy to Hold and announces $26 price target.

Total
0
Shares
Related Posts
Read More

Avidity Biosciences To Present Preliminary Data From Phase 1/2 FORTITUDE Trial Of AOC 1020 In People Living With Facioscapulohumeral Muscular Dystrophy At The 31st Annual FSHD Society International Research Congress

Jeffrey M. Statland, M.D., Professor of Neurology, University of Kansas Medical Center, and FORTITUDE trial investigator, will join Avidity management to present data from FORTITUDE™Avidity to host Volume 9 of

RNA